Australian Law Firm Sues Johnson & Johnson
This is a news story, published by ABC, that relates primarily to Johnson & Johnson news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsABC news
For more news from ABC, you can click here:
more news from ABCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
oral phenylephrine products. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest nasal decongestant news, phenylephrine news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
oral phenylephrineABC
•Class action filed against Johnson & Johnson over 'ineffective' flu medication
63% Informative
Australian law firm files class action against Johnson & Johnson over 'ineffective' cold and flu medication.
If the action is successful, anyone who bought the products in question since 2005 could be compensated.
The action relates to tablets containing phenylephrine, a substance which the US Food and Drug Administration last year declared was not an effective nasal decongestant when taken in tablet form.
VR Score
55
Informative language
50
Neutral language
62
Article tone
semi-formal
Language
English
Language complexity
59
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links